Global Musculoskeletal Disorders Therapeutics Market 2016-2020

Global Musculoskeletal Disorders Therapeutics Market 2016-2020

  • August 2016 •
  • 120 pages •
  • Report ID: 4143797 •
  • Format: PDF
About Musculoskeletal Disorders

Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range of causes, but usually occur depending on the age, lifestyle, and occupation of an individual. Symptoms usually range from recurrent pain, stiffness, and swellings. X-rays and other medical imaging procedures may diagnose the condition. The treatment mainly depends on the severity of the condition. Apart from the drugs, physical therapy, and occupational therapy are also used to manage the condition.

Technavio’s analysts forecast the global musculoskeletal disorder therapeutics market to grow at a CAGR of 4.46% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global musculoskeletal disorder therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat musculoskeletal disorders including osteoarthritis, rheumatoid arthritis, osteoporosis, ankylosing spondylitis, psoriatic arthritis, and fibromyalgia.

The market is divided into the following segments based on geography:
- Americas

Technavio's report, Global Musculoskeletal Disorder Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- AbbVie
- Johnson & Johnson
- Amgen
- Pfizer
- F. Hoffmann-La Roche
- Eli Lilly

Other prominent vendors
- 3SBio
- AB Sciences
- AbGenomics International
- Ablynx
- Adheron
- Akron Molecules AG
- Alder BioPharmaceuticals
- Amgen Astellas BioPharma K.K. in Japan
- Ampio Pharmaceuticals
- Antares Medical Services
- Astellas
- AstraZeneca
- Baxter
- Biocad
- Bioiberica
- Boehringer Ingelheim
- Bone Therapeutics
- Can-Fite BioPharma
- Celgene
- Celltrion
- Cellular Biomedicine
- Cerapedics
- ChemoCentryx
- Chugai Pharmaceutical
- Coherus Biosciences
- Daiichi Sankyo
- Dong-A ST
- Edding Pharm
- Eisai
- Epirus
- Eupraxia Pharmaceuticals
- Flexion Therapeutics
- Galapagos NV
- Gedeon Richter
- Gilead Sciences
- GlaxoSmithKline
- Histogenics
- IBSA Institut Biochimique
- iCeutica
- Iltoo Pharma
- Incyte
- Innovative Med Concepts
- Iroko Pharmaceuticals
- ISTO Technologies
- KaloBios Pharmaceuticals
- KAN Research Institute
- Kang Stem Biotech
- Kitov Pharmaceuticals
- Lexicon Pharmaceuticals
- LG Life Sciences
- Medivir
- Merck
- Mereo
- Mesoblast
- MorphoSys
- Morphotek
- Mycenax
- Neomed Institute
- Novartis
- Omeros
- OrthoTrophix
- Osteologix
- OxyPharma
- PFEnex
- Philogen
- PhytoHealth
- Plexxikon
- PLx Pharma
- Protalex
- Proximagen
- Radius Health
- Regeneron Pharmaceuticals
- Samsung Bioepis
- Samumed
- Sandoz
- Sanofi
- SantoSolve AS
- Steminent Biotherapeutics
- Stempeutics Research
- Taiwan Liposome Company
- Takeda
- Tarsa Therapeutics
- Techfields Pharma
- Tetec AG
- TheraMAB
- TiGenix
- TissueGene
- Tonix Pharmaceuticals
- Translational Biosciences
- Vericel
- Vertex Pharmaceuticals
- Vitaeris
- Winston Laboratories
- Zosano Pharma

Market driver
- Tentative approval of advanced drugs
- For a full, detailed list, view our report

Market challenge
- Growing preference toward surgeries
- For a full, detailed list, view our report

Market trend
- Ongoing active clinical trials for biosimilars
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


We are very sorry, but an error occurred.
Please contact if the problem remains.